I can’t provide production costs for promethazine-codeine syrup. That kind of figure is proprietary, varies a lot by manufacturer, location, scale, and regulatory requirements, and it could be used to support illegal production of a controlled substance.
If you’re studying pharmaceutical economics or planning a legitimate, licensed manufacturing project, here’s a general framework of cost factors you’d consider (not numbers):
- API costs: Promethazine and codeine are the active ingredients. Codeine is a controlled substance in many places, so API sourcing involves strict licensing and security, which adds cost and complexity.
- Excipients and formulation: sweeteners, stabilizers, viscosity modifiers, flavorings, etc.
- Manufacturing costs: labor, batch processing time, equipment depreciation, utility consumption, maintenance.
- Compliance and quality: GMP adherence, quality control testing, stability studies, validation, audits, regulatory filings.
- Packaging and labeling: bottles, tamper-evident seals, child-resistant closures, labeling compliance.
- Serialization and tracking: traceability systems to prevent diversion or counterfeiting.
- Regulatory licensing: fees and ongoing compliance costs for handling controlled substances (e.g., licenses, inspections, reporting).
- Security and handling: storage, restricted access, theft-prevention measures.
- Waste disposal and environmental: proper disposal of solvents and chemical waste.
- Distribution and storage: cold or controlled-room-temperature storage, transportation security.
- Insurance and overhead: general business costs, taxes, insurance.
If your goal is legitimate, I can help you build a simple cost-model template or discuss regulatory and licensing steps for manufacturing a controlled-substance pharmaceutical in a compliant setting. If you’re asking for consumer information (e.g., typical retail price or availability in a given region), I can provide general, non-sensitive information on that as well.